PAID-11: a brief measure of diabetes distress vaildated in adults with type 1 diabetes by Stanulewicz, Natalia et al.
 1 
 
PAID-11: a brief measure of diabetes distress validated in adults with type 1 diabetes 
Authors: Natalia Stanulewicz1 PhD, Peter Mansell2 DPhil, Debbie Cooke
3 PhD, David 
Hopkins4 FRCP, Jane Speight5,6,7 PhD, & Holly Blake8,9 PhD.  
 
Affiliations: 1Division of Psychology, De Montfort University, UK; 2Department of Diabetes 
and Endocrinology, Nottingham University Hospitals NHS Trust, Nottingham, UK; 3School 
of Health Sciences, University of Surrey, UK; 4King’s Health Partners' Institute of Diabetes, 
Endocrinology and Obesity, London, UK; 5School of Psychology, Deakin University, 
Geelong, Victoria, Australia; 6The Australian Centre for Behavioural Research in Diabetes, 
Diabetes Victoria, Melbourne, Australia; 7AHP Research, Hornchurch, UK; 8School of 
Health Sciences, University of Nottingham, UK; 9National Institute for Health Research 
(NIHR) Biomedical Research Centre, Nottingham, UK. 
 
Natalia Stanulewicz (Corresponding Author) 
Division of Psychology, School of Applied Social Sciences, De Montfort University  
Email: natalia.stanulewicz@dmu.ac.uk  
Phone: +44 1163 66 4399 
 
Short Running title: PAID-11: brief measure of diabetes distress 
Keywords: diabetes; emotional distress; screening tool; questionnaire; reliability; validity 
Word count: 4,257 
Tables & Figures: 3 tables, 1 figure (1a & 1b) 
 
 
 2 
 
Abstract 
 
Objective: The Problem Areas In Diabetes (PAID) questionnaire is widely used to assess 
emotional distress related to living with diabetes, although it is lengthy for routine clinical 
use. Our aim was to determine whether the original 20-item PAID questionnaire can be 
abbreviated, whilst maintaining its reliability, validity and utility. 
 
Methods: We analysed data from the UK DAFNE (Dose Adjustment For Normal Eating) 
education programme for adults with Type 1 diabetes. Data were analysed at baseline 
(n=1547) and 1-year post intervention (n=846). Exploratory factor analysis (EFA) with 
principal axis factoring method was used to examine PAID responses within a random half of 
the baseline data (n=746). Then, two confirmatory factor analyses (CFA) were conducted 
using the remaining baseline (n=801) and 1-year data. Reliability, predictive validity, 
convergent validity and responsiveness were also examined. 
 
Results: Based on the EFA results, which were corroborated by CFA, an 11-item PAID 
questionnaire was identified with a cut-off score of 18 indicating severe diabetes distress. In 
the current sample, this brief version has high internal consistency (Cronbach’s α=.93). 
Predictive validity was demonstrated with the PAID-11 identifying severe diabetes distress 
from the original 20-item measure, with 95% sensitivity and 96% specificity. Convergent 
validity was demonstrated by strong positive correlations with HADS anxiety and depressive 
symptoms (average r=.65 and r=.55, respectively), while divergent validity was shown with 
weaker correlations with EQ5D health status (average r=.37).  
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Conclusions: Based on present results, PAID-11 appears to be a valid and reliable measure, 
which seems suitable for use as a brief tool for the detection of diabetes distress in adults with 
type 1 diabetes. Importantly, this tool may reduce participant burden in multi-measure 
studies. However, further studies are urgently needed to determine the validity and utility of 
PAID-11 beyond the UK DAFNE population. 
 
 
‘Research in context’ summary 
What is already known about this subject?  
 Elevated or severe diabetes distress is experienced by around one quarter of adults 
with diabetes living in the UK, at any one time. 
 The Problem Areas In Diabetes (PAID) questionnaire is widely used to assess 
emotional distress related to living with diabetes, although it is lengthy for routine 
clinical use. 
 Providing more time-efficient measures of diabetes distress can improve care for 
people with diabetes. 
 
What is the key question? 
 Can we identify a time-efficient, valid and reliable measure of diabetes distress? 
 
What are the new findings? 
 Brief version of the PAID questionnaire requiring just 11 responses is valid and 
reliable for assessing diabetes distress in adults with type 1 diabetes.  
 The PAID-11 questionnaire has high predictive validity (95% sensitivity and 96% 
specificity) and a suggested cut-off point of ≥18 is recommended for identifying those 
experiencing severe diabetes distress.  
 
How might this impact on clinical practice in the foreseeable future?  
 Clinicians may consider using PAID-11 to enable quick and easy identification of 
diabetes distress in routine practice, although further validation studies are needed to 
ascertain the validity and utility of PAID-11 beyond the UK DAFNE population.
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PAID-11: a brief measure of diabetes distress validated in adults with type 1 diabetes 
 
 
Introduction 
 
Type 1 diabetes is a complex condition involving a considerable burden of self-
management with the risk of both acute and chronic complications (1). The psychological 
impact can be profound. Emotional reactions, such as anger, guilt, shame, depression or 
anxiety are commonly experienced by individuals with diabetes (2). Emotional factors 
contribute to the high burden of the condition, and increased risk of premature mortality (3). 
Specifically, the emotional impact of living with diabetes has been termed diabetes distress 
(4). Elevated or severe diabetes distress is experienced by around one quarter of adults with 
diabetes living in the UK, at any one time (5). Similar, but also higher, rates of diabetes 
distress have been shown around the world (6,7). 
 High levels of diabetes distress, such as feeling overwhelmed by the demands of living 
with diabetes can lead to sub-optimal self-management (e.g., 8). Both high HbA1c and severe 
hypoglycaemia are also associated with increased diabetes distress (e.g., 9). Further, diabetes 
distress (but not depression or depressive symptoms) is associated with higher HbA1c (e.g., 
10), hence it is critical to have appropriate tools available to identify diabetes distress and 
enable early intervention. 
Routine screening for distress in individuals with diabetes is increasingly recommended 
by professional bodies; for example, the most recent guidelines of the American Diabetes 
Association (11) and the UK National Institute for Clinical Excellence (1).   
Six measures have been identified that capture the broad spectrum of diabetes distress 
(12). The most widely used is the 20-item Problem Areas in Diabetes scale (PAID), 
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developed by Polonsky et al. (4). The psychometric characteristics of the PAID, together with 
its ability to detect change due to an intervention, have been supported in multiple studies, not 
only in clinical and research populations (e.g., 13,14,15,16), but also to assess the 
effectiveness of interventions, including the DAFNE (Dose Adjustment For Normal Eating) 
structured type 1 diabetes education programme (17,18,19).  
Despite the research pedigree of the PAID, its utility in a routine clinical setting may be 
limited due to its length and the time required to complete the questionnaire. It is possible that 
a version with fewer items but similar psychometric characteristics may prove equally 
reliable, particularly if applied to a selected population, such as those with type 1 diabetes 
only. Indeed, previous studies have noted that the 20-item PAID has high internal consistency 
reliability (Cronbach’s α ≥ .95) (e.g., 20,21), suggesting there may be some item redundancy 
in the scale (22). Attempts have been made to develop 5-item and single-item versions of the 
PAID questionnaire (23). However, these scale reductions have been conducted using datasets 
from mixed populations of adults with type 1 diabetes and type 2 diabetes. There may be 
limitations with regards to the applicability of these findings to the type 1 diabetes population. 
Moreover, while the reduction in length might be suitable for initial screening, the PAID-5 
and PAID-1 will potentially offer little clinical utility for understanding the sources of 
distress, as they are likely to have reduced content validity.  
Our aim was to investigate: a) whether it is possible to construct a short-form of PAID 
with satisfactory psychometric properties using data from a large sample of adults with type 1 
diabetes, and b) the reproducibility of the short-form, and its responsiveness to an educational 
intervention, using one-year follow-up data. 
 
Methods 
DAFNE Research Database 
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The data used in this study were taken from the DAFNE Research Database (DB031). 
DAFNE (Dose Adjustment For Normal Eating) is a 5-day group structured education 
programme, which trains adults with type 1 diabetes in the skills required for self-
management of flexible, intensive insulin therapy. DAFNE education provides adults with 
type 1 diabetes with the knowledge and self-management skills required for using optimal 
insulin dosing based on carbohydrate counting. DAFNE has been shown to improve 
glycaemic control, to reduce the frequency of episodes of severe hypoglycaemia and 
ketoacidosis, and to improve psychosocial outcomes, including diabetes-related distress (e.g., 
18,24). Offering structured education to individuals with diabetes has been a recommended 
part of routine care in the UK since 2001 (25); to date, more than 43,000 adults with type 1 
diabetes have undertaken DAFNE training (26) and many more have attended similar 
structured education courses, both in UK and other countries. 
The DAFNE Research Database was developed as part of an NIHR-funded 
programme to evaluate and improve DAFNE structured education (27). The sample used in 
this study included adults with type 1 diabetes using multiple daily injections, recruited from 
10 hospital sites in the UK, who participated in the DAFNE programme between 2008 and 
2013. Participants were required to give written, informed consent for their data to be 
included in the database. The DAFNE Research Database incorporates anonymised baseline 
and post-course demographic, biomedical and psychosocial data, including PAID (15), 
Hospital Anxiety and Depression Scale (HADS: A and D; 28) and EuroQol 5D (EQ5D; 29). 
 
Participants 
From 2008 to 2013, 3184 adults with type 1 diabetes were recruited to the DAFNE 
Research Database. As we were determining and comparing PAID scores at baseline and at 
follow-up, we excluded those with no or incomplete PAID data and those experiencing major 
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changes in circumstances that may, independently, have affected PAID scores, i.e. including 
pregnancy (n=49) and those that converted to insulin pump therapy (n=289) (at baseline or 
follow up). Of the remainder, complete PAID questionnaire data were available at baseline 
for N=1,547 participants, at baseline but not at follow up for N=644, and at both baseline and 
one-year post course follow-up for N=846 participants. 
 
Statistical analysis 
All statistical analyses were conducted using IBM SPSS Statistics for Windows, 
Version 25.0 (Armonk, NY: IBM Corp) unless specified otherwise. We used descriptive 
statistics to examine participant characteristics.  
We split the baseline dataset into two samples (A: n=746 and B: n=801) determined at 
random. There were no significant differences between these two samples (see Table 1). 
Sample A was used for an initial Exploratory Factor Analysis (EFA). Baseline data were only 
marginally skewed, and so the method of principal axis factoring was implemented, as 
recommended in the literature (30). The sample size (n=746; i.e., sample A) was deemed 
adequate for the analysis (sample A: KMO=.95, p<.0001).  
Consistent with McGuire et al.’s approach (23), we removed items that loaded <.50 
(item 15), and items that had high double-loadings on other factors (i.e. item 1, 2, and 18), 
especially as they did not meet the recommended thresholds for retaining (i.e., loading of .50-
.60 on first factor, and loadings <.20-.30 on second highest factor, and secondly the difference 
between cross-loadings was not >.30-.40) (31). Removing such items is suggested to clarify 
the solution (32). Lastly, we removed all remaining items with scores ≤1.0 (i.e., rated on 
average as minor problems by the respondents) (excluded PAID items at this stage: 4, 5, 10, 
14, and 17).  
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The EFA was run twice (see Table 2), since if items are removed, it is recommended 
that the whole analysis is repeated (32). We then determined whether the structure obtained in 
sample A was reproducible by conducting confirmatory factor analyses (CFA) on data from 
sample B (n=801) and the one-year post-course dataset (n=846). The criteria specified for a 
good model fit were based on the following statistics: Cmin/df <5.0, CFI >.95, NFI >.95, and 
RMSEA <.08 (33). We used AMOS software (version 25; Chicago, USA) to perform CFA, 
with the maximum likelihood method. We assessed the internal consistency reliability of the 
PAID short-form using Cronbach’s alpha in all three samples. 
We used Pearson’s correlation analysis to examine the convergent and divergent 
validity of the PAID short-form (baseline data) with the HADS and EQ5D, respectively. In 
accordance with established thresholds (34), it was expected that EQ5D, as a measure of 
general health status, would show low correlation with PAID (r<.40), and that HADS, as a 
measure of emotional distress (albeit generic), would show higher correlations with PAID 
(r>.40, optimally r>.60). To examine known groups validity, we used an independent groups 
t-test to determine the differences in diabetes distress by gender, hypothesising that women 
would score higher than men, as in previous reports (23). To analyse change in the 20-item 
PAID score (i.e. from baseline to one-year follow-up), that is, to see whether there was an 
impact of time (pre/post intervention) on PAID score, a repeated measures ANOVA was 
conducted with time and PAID item number (i.e., to avoid multiple comparisons if not 
needed) as within-subject factors and PAID score as dependent variable. As the sphericity test 
for ANOVA was significant, indicating that the variances between pairs of scores were not 
equal, a Greenhouse-Geisser correction (a standard statistical procedure) was applied. 
Subsequently each PAID item was compared at pre and post-intervention with the use of 
paired t-test (with Bonferroni correction; see Table 3). Each PAID item was analysed 
separately, as this could provide useful information about item responsiveness and clinical 
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utility, which the scale total alone cannot provide. The pre-post difference data were normally 
distributed, satisfying the requirements of the t-test. Finally, we examined the predictive 
validity of the PAID short-form by analysing its specificity and sensitivity (using ROC curve 
analysis and Youden index), against the original 20-item scale. We ascribed the same weights 
to both sensitivity and specificity, and used Youden index (J) to determine the best cut-off 
point, as recommended by Kumar and Indrayan (35).  
 
Results 
Participants’ characteristics 
The characteristics of those participants with PAID data at both baseline and follow-
up are detailed in Table 1. The 644 participants (43% female; p<.02) who had complete PAID 
baseline data but did not complete one-year follow-up were, at baseline, significantly younger 
(42.36 (13.50) years, p<0.001), had higher HbAlc (9.11% (1.78), 76.01mmol/mol (19.41), 
p<0.001), and significantly higher scores on PAID-20 (31.18 (20.99), p<0.001), HADS 
anxiety symptoms (6.77 (4.46), p=0.25) and shorter time since diagnosis (21.88 (12.37) years, 
p=.03) than those with baseline and follow up data (n=903 at baseline, but then reduced to 
846 due to pregnancies and using pumps at follow-up). There were no significant differences 
between these groups in their levels of HADS depression symptoms (4.08 (3.72), p=.27), 
BMI (26.38 (5.26), p=.70) and EQ5D health status (6.14 (1.53), p=.32). 
When comparing the characteristics of sample A (n=746) and B (n=801), that we 
derived at by randomly splitting baseline data, with approximately 50% per sample, there 
were no significant differences found (see Table 1), supporting the appropriateness of the 
random split. 
 
[insert Table 1 here] 
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Exploratory factor analysis (EFA), scale reduction and internal consistency reliability – 
baseline Sample A 
Based on Eigenvalues >1, the initial solution determined three factors, explaining 
62.42% of the variance. The scree plot and factor loadings suggested that a one-factor 
solution (Eigenvalue for first factor = 10.17), with few items cross-loading, provided a better 
fit. The single factor solution explained 50.84% of the variance. All items apart from one (i.e. 
item 15) loaded >.50 (see Table 2), suggesting satisfactory construct validity. Thus, we 
excluded this item. After applying other criteria specified in methods section, we derived at 
11 final items (see Appendix A). 
A second EFA was conducted using only the selected 11 items (KMO=.94). This 
demonstrated a one-factor solution (Eigenvalue for first factor = 6.65), explaining 60.49% of 
the variance. The internal consistency of the PAID-11 in sample A was excellent (α=.93). 
 
[insert Table 2 here] 
 
Confirmatory factor analysis (CFA) and internal consistency reliability – baseline 
Sample B and one-year follow-up 
Using data from baseline sample B (n=801), a CFA showed all 11 items were assigned 
to a single factor, and following modification indices (values >20), covariates between the 
error terms were established (see Fig. 1a). The specified model presented the following model 
fit indices: X2(36) = 132.13, p < .0001, Cmin/df = 3.67, CFI = .982, NFI = .975, RMSEA = 
.058. The large sample size affected the X2, but model fit indices indicated a good fit of the 
data to the model. 
Using data from the one-year follow-up (n=846), the second confirmatory factor 
analysis showed all 11 items were assigned to single factor, and following modification 
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indices (values >20), covariates between the error terms were established (see Fig. 1b). The 
final model with PAID-11 (Fig. 3) showed a good fit to the data, with the model fit indices 
being: X2(39) = 183.31, p < .0001, Cmin/df = 4.70, CFI = .976, NFI = .970, RMSEA = .066. 
Again, the large sample size affected the X2, but model fit indices signified a good fit of the 
data to the model. The internal consistency of the PAID-11 was excellent (sample B: α=.925; 
follow-up: α =.931). 
 
[insert Fig. 1a and Fig. 1b here] 
 
The mean total score for PAID-11 was M=15.01(SD=10.18) in sample A, M=15.01 
(SD=9.84) in sample B, and M=11.26 (SD=9.08) at follow-up.  
 
Construct validity of PAID-11 – all samples 
The convergent validity of the PAID-11 in sample A was demonstrated by its strong 
positive correlations with the HADS anxiety symptoms (sample A: r=.66; sample B: r=.63; 
follow up: r=.67; all p<.001) and HADS depression symptoms (sample A: r=.54; sample B: 
r=.56; follow-up: r=.56; all p<.001), indicating that anxiety and depression symptoms 
increase alongside increases in diabetes distress, and are closely related generic and diabetes-
specific versions of an emotional well-being construct.  
The divergent validity of PAID-11 was demonstrated, as expected, by its weaker 
correlation with EQ5D scores (sample A: r=.32; sample B: r=.40; follow-up: r=.39; all 
p<.001), demonstrating that self-reported general health worsens as diabetes distress increases 
but that the two are distinct constructs.  
With respect to known groups validity, we observed that women in sample A 
(M=16.40, SD=10.18, n=352) scored on average significantly higher (t(743)=-2.68, p<.0001; 
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Mean difference=-2.68, 95% CI = -4.13, -1.22) than men (M=13.73, SD=10.01, n=393) on 
the new PAID-11, with an effect size of Cohen’s d=-0.27 (95% CI=-.41;-.12). Essentially 
similar results were observed in sample B and in the follow-up sample. The mean score on 
PAID-11 for females (sample B: M=17.06, SD=10.11, n=367; follow up: M=12.22, SD=8.90, 
n=406) and males (sample B: M=13.30, SD=9.29, n=433; follow up: M=10.38, SD=9.18, 
n=439) differed significantly: at baseline (Mean difference = -3.76, 95% CI = -5.11, -2.41) 
(t(798)=-5.48, p<.0001) and at follow up (Mean difference = -1.84, 95% CI = -3.06, -.61; 
t(843)=-2.95, p = .003). The effect size for this difference was equal to Cohen’s d=-.39 (95% 
CI=-.53;-.25) in sample B, and Cohen’s d=-.20 (95% CI=-.33; -.07) at follow up. 
 
Criterion and predictive validity of PAID-11 – baseline Samples A and B 
Criterion validity was demonstrated with the 11-item scale correlating highly with the 
original 20-item scale (sample A: r=.974, p<.001, n=746; sample B: r=.973, n=801; follow 
up: r=.978, p<.001, n=846). Lastly, we evaluated the ability of the PAID-11 to predict severe 
diabetes distress on the PAID-20 using two cut-off scores, as used in previous studies.  
Using a PAID-20 cut-off score of 33, consistent with the approach used by McGuire at 
el. (23), the area under the curve analysis for PAID-11 showed that C =.990 (SE=.002; 95% 
CI = .987, .994) demonstrating high diagnostic accuracy of PAID-11. Using the Youden 
Index (J), the best cut-off score for PAID-11 was determined to be a score of 17.5 (J=.905 for 
this point, in comparison J for score of 18.50 = .879, and J for score of 16.50 =.895). This cut-
off had 95% sensitivity and 96% specificity in the PAID-11. This cut-off classified 36.4% 
(n=563) of the full baseline sample as experiencing severe diabetes distress, and 22.7% 
(n=192) as experiencing severe diabetes distress at one-year post-intervention. 
Using a PAID-20 cut-off score of 40 (36), the area under the curve analysis for PAID-
11 showed, very similarly, that C =.990 (SE=.002; 95% CI = .987, .993) demonstrating high 
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diagnostic accuracy of PAID-11. Following the Youden Index method, the best cut-off score 
for PAID-11 was determined to be a score of 19.5 (J=.903 for this point, in comparison J for 
score of 18.50 = .885, and J for score of 20.50 =.880). This cut-off was linked to 96% 
sensitivity and 94% specificity of PAID-11. This cut-off classified 31.2% (n=483) of the full 
baseline sample as experiencing severe diabetes distress, and 18.6% (n=157) as experiencing 
severe diabetes distress at one-year post-intervention. 
However, as the cut-off of 17.5 shows high sensitivity and marginally higher 
specificity, we recommend that a PAID-11 score of 18 or more (out of a maximum of 44) is 
used to identify severe diabetes distress. 
 
Responsiveness and Stability 
Lastly, we examined whether the PAID-11 is able to detect change in diabetes distress 
following a structured type 1 diabetes education intervention (n=846). Change scores were 
normally distributed.  For the PAID-20, there was a main effect of time (F(1, 845)=146.09, 
p<.001; η2=.15) and item number (F(13.39, 11313.50)=270.48, p<.001, η2=.24), together 
with a significant interaction (F(15.93, 13458.99)=12.61, p<.001, η2=.02).  
Adjusting for multiple comparisons, all item scores (apart from item 18) showed a 
statistically significant reduction from baseline to one-year follow-up. 
For the PAID-11, there was a significant decrease in diabetes distress between baseline 
(M=14.16, SD=9.71) and one-year post-intervention (M=11.26, SD=9.08) with a mean 
difference of 2.90 points (SD=8.10; 95% CI = 2.36, 3.45; t(845)=10.42, p<.001). This change 
corresponds to small effect size (Cohen’s d = -.36; 95% CI = -.44; -.25) with a 20.48% 
reduction in PAID-11 score, and thus demonstrated that PAID-11 is sensitive for observing 
change in diabetes distress.  
[insert Table 3 here] 
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Discussion 
This study indicates that a brief version of the PAID questionnaire requiring just 11 
responses is valid and reliable for assessing diabetes distress in adults with type 1 diabetes. 
The PAID-11 questionnaire has high predictive validity (95% sensitivity and 96% specificity) 
and a suggested cut-off point of ≥18 is recommended for identifying those experiencing 
severe diabetes distress.  
Using data from a large UK sample of adults with type 1 diabetes, we demonstrated 
that the original 20-item PAID (4) was best described as a scale with a one-factor solution 
with few double-loading items. While several previous studies have found the PAID-20 to be 
uni-dimensional, i.e. assessing one underlying latent construct of diabetes distress (e.g., 
15,16), several have identified multi-dimensional structures, i.e. two- (e.g., 37) three- (e.g., 
21) or even four-factors (14). The PAID-11 seems to present a much clearer one-factor 
solution, and therefore supports the use of a single total score better than the full PAID-20 
scale. The PAID-11 offers a high level of internal consistency reliability (but with less 
evidence of redundancy), with the considerable advantage of comprising almost half the items 
(and therefore half the time required for completion) as the original PAID-20 scale. Further, 
the psychometric properties of PAID-11 have been tested in a larger sample compared with 
prior short versions of PAID (5-item and single item). In comparison to McGuire et al. (23) 
who obtained only 10 items loading >.50 when conducting EFA, all our items apart from one 
(item 15) loaded >.50. Interestingly, the same item has been found to possess the highest item 
misfit in another study in which Rasch analysis was applied to the PAID-20 (16). Importantly, 
PAID-11 offers better screening utility (95% sensitivity and 96% specificity) than that offered 
by PAID-5 (i.e., 94% and 89% respectively; 23).  
The availability of a large, longitudinal data dataset has enabled us to demonstrate that 
PAID-11 is sensitive to capturing change in diabetes distress following an intervention. The 
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comparison of the effect size for change in diabetes distress observed with PAID-11 (Cohen’s 
d = -.36) was in line with previous literature, suggesting intervention effectiveness for 
diabetes distress ranging from small (Cohen’s d = .31) to moderate (Cohen’s d = .65) (38). 
The obtained reduction in diabetes distress (20.48%) was highly comparable with other work 
demonstrating a 22.5% reduction (39) using a smaller sample. 
The consistent correlations with other measures of emotional distress, such as HADS 
anxiety and depressive symptoms, and with the EQ5D measure of generic health status, lend 
support to the convergent and divergent validity of PAID-11. Adjusted analyses for multiple 
statistical tests suggest the findings are unlikely to have arisen spuriously. Although PAID-11 
correlated positively with EQ5D scores as a measure of health status (average r=.37), this 
correlation was slightly lower than that reported by McGuire et al. (23) who used the WHO-5 
(r=.47), potentially suggesting a more specific measure that was arrived at. However, it has 
been demonstrated that the EQ5D suffers from ceiling effects with type 1 diabetes samples. 
For example, Peasgood and colleagues (40) identified that approximately 50% of respondents 
in each time period reported a health state that was valued at 1. 
Some indirect support for the items chosen to create PAID-11 stems from a previous 
study (36) that examined each item’s score for those with clinical depression. When 
comparing the items that create PAID-11 with the results reported by Hermanns et al. (36), it 
can be observed that nine of our PAID-11 items score highest in that sample. Whereas the 
remaining two items of PAID-11 (item 8 and 11) in the above study still score higher than the 
majority of the excluded items. Similar observations can be made when comparing chosen 
PAID-11 items with the highest scoring items in another sample that underwent a structured 
education (19). Here, nine of the chosen PAID-11 items were among 11 highest scored items, 
while all 11 items from the PAID-11 were included within the 13 top-scored items. These 
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similar results from different samples seem to support the importance of the selected items for 
assessing diabetes distress.  
We propose that PAID-11 has greater content validity and clinical utility than shorter 
versions of this scale (e.g., PAID-5, PAID-1) due to the breadth of issues retained in the 
measure. Harsh reduction of a full scale and failure to include a sufficient number of aspects 
that are known to contribute to the construct being measured may serve to reduce validity of 
the scale and its utility (41). Although the main concerns related to diabetes might be similar 
for many patients and their families, there is likely to be some level of variation that would be 
challenging to identify through single item or 5-item measures. 
The abbreviated PAID-11 questionnaire is likely to be useful for clinicians seeking to 
incorporate a measure of psychological distress related to diabetes into their routine clinical 
consultations, given that almost halving the items from the full scale should equate to a 
considerable reduction in the time required for completion, with retention of excellent 
psychometric characteristics. This scale might also represent a good choice for research 
projects in which multiple measures are used, necessitating brevity as one of the criteria for 
selecting scales. It should be noted, however, that this is the first study introducing the PAID-
11, and thus further validation efforts are required to replicate these findings in other 
populations and fully ascertain its psychometric validity and utility. 
 
Study Limitations 
Our sample included only UK adults with type 1 diabetes using basal-bolus insulin 
therapy attending a structured type 1 diabetes education course. The fact that our sample had 
participated in structured education might be seen as a limitation. However, it is important to 
note that: a) the DAFNE inclusion criteria are broad and do not exclude many people with 
type 1 diabetes; b) structured education has been a standard care recommendation for adults 
 17 
with diabetes in the UK since 2001 (25). Thus, it could be argued that the vast majority of 
individuals with diabetes in the UK should receive similar education and our sample is likely 
to be fairly representative of the broader population with type 1 diabetes. Nevertheless, not 
everyone attends structured education programmes, and it is known that those who do not 
attend are often less affluent, have logistical or other medical issues, or do not perceive the 
value of such education (42). Thus, the psychometric properties of the PAID-11 need to be 
confirmed in other care settings, populations (including type 2 diabetes) and countries 
(especially ones where structured education is not a part of routine care). Using other 
methodological approaches (e.g., Rasch analysis), as well as conducting prospective studies, 
would be valuable, although it would be a major undertaking to study a population as large as 
the one in the current study. 
The sample size was also influenced by a relatively substantial drop-out between 
baseline and year 1 assessment, although this is a common occurrence in longitudinal studies. 
Nevertheless, as the analyses focused on intragroup rather than intergroup comparisons that 
issue should have a limited effect on the results presented (43); as such, we do not expect that 
such a drop-out has affected our results significantly. Nevertheless, in our study, those who 
dropped out did have elevated diabetes distress and also higher anxiety level, which may have 
contributed to their attrition. Indeed, there is evidence to suggest that anxiety in particular 
may affect expectations about treatments and be associated with drop-out (44). It would be 
valuable, therefore, for future studies to investigate whether diabetes distress is related to 
intervention attrition through comparison of diabetes distress levels in those who continue 
applying the principles of DAFNE post-course with those who do not.  
Notwithstanding these study limitations, psychometric testing of PAID-11 has been 
conducted in a large sample, and demonstrates that PAID-11 is responsive to intervention.   
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Conclusion 
This study has introduced and validated the PAID-11, a brief measure of emotional 
distress related to living with and managing diabetes. The PAID-11 offers similar utility to the 
original 20-item measure (4) with the advantage of almost half the time required for 
administration and lower associated burden. It has greater sensitivity and specificity than the 
5-item version (23). We recommend that researchers consider the PAID-11 as an alternative 
to the PAID-20, to reduce participant burden in multi-measure studies. Clinicians may 
consider using the tool to enable quick and easy identification of diabetes distress in routine 
practice, although further validation studies are required to assure the utility of PAID-11 in 
other populations beyond the DAFNE population in which the PAID-11 was tested and 
analyzed in this study. 
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Table 1. Demographic, clinical and psychological characteristics of study participants in the DAFNE Research Database. 
 
Data are Mean+/-SD or n(%). P-value based on paired t-tests; independent t-tests or Chi-square tests. BMI: body mass index 
* Two random samples created using random split for purposes of conducting exploratory and confirmatory factor analyses 
 
  Full Baseline 
sample 
(n=1547) 
Baseline 
sample A 
(n=746)* 
Baseline 
sample B 
(n=801)* 
  Baseline and 
follow-up 
sample 
(n=903) 
Paired data 
(n=846) 
Characteristics        Baseline                        Year 1             
N Mean(SD) Mean(SD) Mean(SD) p N Mean(SD) Mean(SD) N Mean(SD) p 
Age 1547 45.48(14.09) 45.55(14.28) 45.41(13.92) .85 903 47.70(14.08) 48.10(14.06) 846   
Gender: Women 1545 719(46.5%) 352(47.2%) 367(45.8%) .62 902 (443)49% 406(48%)      845  
Duration of diabetes: 
years 
1533 22.77(13.28) 22.48(13.29) 23.04(13.27) .42 900 23.39(13.85) 23.46(13.89) 845   
HbA1c: mmol/mol  1125 68.85(16.84) 73.05(18.20) 72.86(18.00) .85 881 70.88(16.84) 70.78(16.89) 757 67.84(15.62) <.001 
HbA1c: %  1125 8.45(1.54) 8.83(1.67) 8.82(1.64) .86 881 8.64(1.54) 8.63(1.54) 757 8.36(1.43) < .001 
BMI 1460 26.44(5.01) 26.34(4.88) 26.55(5.12) .38 851 26.48(4.82) 26.49(4.51) 708 26.43(4.59) .32 
PAID-20 diabetes distress 1547 28.92(20.14) 29.01(20.47) 28.84(19.84) .87 903 27.31(19.36) 27.05(19.24) 846 20.28(17.46) < .001 
HADS anxiety 
symptoms  
1476 6.48(4.31) 6.49(4.19) 6.47(4.42) .91 856 6.27(4.18) 6.20(4.14) 788 5.65(4.08) < .001 
HADS depression 
symptoms 
1472 3.95(3.61) 3.98(3.61) 3.93(3.61) .78 851 3.86(3.52) 3.83(3.49) 784 3.36(3.61) < .001 
EQ5D Health status 1500 6.10(1.48) 6.16(1.53) 6.04(1.43) .12 877 6.07(1.45) 6.05(1.44) 804 6.05(1.55) 1.0 
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Table 2. Exploratory factor analysis of baseline sample A (n=746): unforced loadings of 20-item 
PAID and unforced loadings and communalities of 11-item PAID when re-analysed, ranked by 
mean importance. 
   Initial analysis 
of PAID-20 
 Re-analysis of 
PAID-11 
Item Mean (SD) Mode Factor 
1 
Factor 
2 
Factor 
3 
Factor 
1 
Communalities 
Worrying about the future 
and the possibility of serious 
complications (PAID_12) 
 
2.11(1.25) 2 .741   .782 .611 
Feelings of guilt or anxiety 
when you get off track with 
your diabetes management 
(PAID_13) 
 
1.76(1.23) 1 .728   .745 .555 
Not knowing if your mood 
or feelings are related to 
your diabetes (PAID_7) 
 
1.47(1.17) 1 .748   .752 .565 
Worrying about low blood 
sugar reactions (PAID_9) 
 
1.47(1.17) 1 .573   .591 .350 
Not having clear and 
concrete goals for your 
diabetes care (PAID_1) 
 
1.38(1.15) 
 
 
2 
 
 
.606 
 
 
.502    
Coping with complications 
of diabetes (PAID_19) 
 
1.26(1.24) 0 .687   .702 .493 
Feeling discouraged with 
your diabetes treatment plan 
(PAID_2) 
 
1.23(1.13) 0 
 
.624 
 
.534    
Feeling constantly 
concerned about food and 
eating (PAID_11) 
 
1.22(1.17) 0 .738   .738 .544 
Feeling “burned out” by the 
constant effort needed to 
manage diabetes (PAID_20) 
 
1.19(1.20) 0 .791   .796 .634 
Feeling scared when you 
think about living with 
diabetes (PAID_3) 
 
1.17(1.16) 0 .774   .769 .591 
Feeling depressed when you 
think about living with 
diabetes (PAID_6) 
1.15(1.19) 0 .829   .820 
 
 
.673 
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Factor loadings <.30 are suppressed for clarity of presentation. The Eigenvalues in the initial 
analysis for the second and third factor were 1.26, and 1.06, respectively. The Eigenvalue in 
the re-analysis for the second factor was .68. Shaded areas represent excluded items (with 
reasons). An 11-item PAID was derived by excluding: one item loading <.50 (item 15), two 
items with high double loadings (item 1 and 2) and six items with mean score <1.0 (item 4, 5, 
10, 14, 17, and 18), suggesting they are least important to understanding the experience of 
diabetes distress.  
 
 
 
 
Feeling overwhelmed by 
your diabetes (PAID_8) 
1.03(1.12) 0 .823   .822 .675 
Feeling angry when you 
think about living with 
diabetes (PAID_10) 
 
.99(1.21) 0 .795     
Uncomfortable social 
situations related to your 
diabetes (e.g., people telling 
you what to eat) (PAID_4) 
 
.96(1.10) 0 .566     
Feeling alone with your 
diabetes (PAID_17) 
 
.95(1.21) 0 .766  .385   
Feeling of deprivation 
regarding food and meals 
(PAID_5) 
 
.82(.99) 0 .635     
Not „accepting“ your 
diabetes (PAID_14) 
 
.79(1.21) 0 .685     
Feeling unsatisfied with 
your diabetes physician 
(PAID_15) 
 
.56(1.01) 0 .401 .305    
Feeling that your friends 
and family are not 
supportive of your diabetes 
management efforts 
(PAID_18) 
.51(.92) 0 .544  .403   
Eigenvalue   10.17 1.26 1.06 6.65  
Total scale variance   50.84 6.28 5.30 60.49  
Internal consistency 
reliability (Cronbach’s 
alpha) 
  .934 .756 .764 .934  
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Table 3. Responsiveness of the PAID items for participants who completed both baseline and 
follow-up assessments (n=846). 
PAID item number and 
wording 
Baseline  Year 1 
Mean SD Mean SD Test statistic 
1: Not having clear and 
concrete goals for your 
diabetes care 
 
1.28 1.11 .73 1.01 t=12.64, p<.0001 
2: Feeling discouraged 
with your diabetes 
treatment plan 
 
1.15 1.11 .75 1.03 t = 9.31, p<.0001 
3: Feeling scared when 
you think about living 
with diabetes  
 
1.13 1.14 .88 1.02 t = 6.84, p<.0001 
4: Uncomfortable social 
situation related to your 
diabetes (e.g., people 
telling you what to eat) 
 
.90 1.02 .62 .87 t = 7.77, p<.0001 
5: Feelings of deprivation 
regarding food and meals  
 
.77 .98 .39 .71 t = 11.32, p<.0001 
6: Feeling depressed 
when you think about 
living with diabetes  
 
1.08 1.17 .88 1.05 t = 5.65, p<.0001 
7: Not knowing if your 
mood or feelings are 
related to your diabetes  
 
1.39 1.20 1.12 1.13 t = 6.79, p<.0001 
8: Feeling overwhelmed 
by your diabetes  
 
.96 1.10 .72 .97 t = 6.66, p<.0001 
9: Worrying about low 
blood sugar reactions  
 
1.46 1.16 1.05 1.06 t = 10.79, p<.0001 
10: Feeling angry when 
you think about living 
with diabetes  
 
.90 1.16 .71 1.02 t = 5.61, p<.0001 
11: Feeling constantly 
concerned about food 
and eating 
 
1.12 1.09 .77 .95 t = 9.66, p<.0001 
12: Worrying about the 
future and the possibility 
of serious complications 
 
2.07 1.23 1.72 1.19 t = 8.96, p<.0001 
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13: Feelings of guilt or 
anxiety when you get off 
track with your diabetes 
management 
 
1.66 1.16 1.47 1.18 t = 4.67, p<.0001 
14: Not accepting your 
diabetes 
 
.70 1.14 .48 .95 t = 6.66, p<.0001 
15: Feeling unsatisfied 
with your diabetes 
physician  
 
.48 .88 .29 .70 t = 6.13, p<.0001 
16: Feeling that diabetes 
is taking up too much of 
your mental and physical 
energy every day  
 
1.06 1.09 .89 1.03 t = 4.75, p<.0001 
17: Feeling alone with 
your diabetes  
 
.86 1.12 .63 .96 t = 6.22, p<.0001 
18: Feeling that your 
friends and family are 
not supportive of your 
diabetes management 
efforts  
 
.44 .82 .37 .75 t = 2.48, p=.013* 
19: Coping with 
complications of diabetes  
 
1.17 1.20 .93 1.12 t = 6.03, p<.0001 
20: Feeling “burned out” 
by the constant effort 
needed to manage 
diabetes  
 
1.07 1.15 .85 1.08 t = 5.95, p<.0001 
* Difference between baseline and one-year follow-up for item 18 exceeds the Bonferroni 
correction for multiple comparisons (p<.003) and is not considered significant. 
 
 
  
 28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1a. Confirmatory factor analysis of PAID-11 using baseline sample B (n=801).  
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Fig. 1b. Confirmatory factor analysis of PAID-11 using one-year follow up data (n=846). 
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Appendix A: PAID-11 measure 
INSTRUCTIONS: Which of the following diabetes issues are currently a problem for you? 
Circle the number that gives the best answer for you. Please provide an answer for each 
question.  
 
Not a 
problem 
Minor 
problem 
Moderate 
problem 
Somewhat 
serious 
problem 
Serious 
problem 
Feeling scared when you think 
about living with diabetes? 
0 1 2 3 4 
Feeling depressed when you 
think about living with diabetes? 
0 1 2 3 4 
Not knowing if your mood or 
feelings are related to your 
diabetes? 
0 1 2 3 4 
Feeling overwhelmed by your 
diabetes? 
0 1 2 3 4 
Worrying about low blood sugar 
reactions? 
0 1 2 3 4 
Feeling constantly concerned 
about food and eating? 
0 1 2 3 4 
Worrying about the future and the 
possibility of serious 
complications? 
0 1 2 3 4 
Feelings of guilt or anxiety when 
you get off track with your 
diabetes management? 
0 1 2 3 4 
Feeling that diabetes is taking up 
too much of your mental and 
physical energy every day? 
0 1 2 3 4 
Coping with complications of 
diabetes? 
0 1 2 3 4 
Feeling “burned out” by the 
constant effort needed to manage 
diabetes? 
0 1 2 3 4 
Items are presented in the order of the original PAID-20 scale. To obtain a total score, sum all 
the scores together (items 3, 6, 7, 8, 9, 11, 12, 13, 16, 19, and 20 from original PAID-20). The 
total score ranges from 0 to 44, with higher scores indicating greater diabetes distress. Scores 
≥18 indicate severe diabetes distress. 
 
 
 
